Dec 20 (Reuters) - Merit Medical Systems Inc MMSI.O:
MERIT MEDICAL ANNOUNCES FDA APPROVAL OF THE WRAPSODY CELL-IMPERMEABLE ENDOPROSTHESIS
TO BEGIN COMMERCIALIZATION OF WRAPSODY IN USA IN 2025
Source text: ID:nGNX2mZDYk
Further company coverage: MMSI.O
((Reuters.Briefs@thomsonreuters.com;))